Harman Patil (Editor)

Arena Pharmaceuticals

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
Type  Public (NASDAQ: ARNA)
Founded  1997
CEO  Amit Munshi (May 2016–)
Industry  Biotechnology
Products  Belviq
Revenue  27.6 million USD (2012)
Arena Pharmaceuticals httpsstaticseekingalpha1asslfastlynetimage
Key people  Jack Lief, cofounder Dominic Behan, co-founder and senior scientist Amit Munshi, CEO Kevin Lind, CFO
Operating income  US$−57,000,000 (FY 2012)
Stock price  ARNA (NASDAQ) US$ 1.55 -0.02 (-1.27%)28 Feb, 2:26 PM GMT-5 - Disclaimer
Headquarters  San Diego, California, United States
Founders  Jack Lief, Dominic P Behan

David arena pharmaceuticals inc


Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has one product on the market and several others in development. In 2016 the company downsized and said it would shift its focus to developing new drugs currently being tested in clinical trials.

Contents

14 55633 carl schwartz v arena pharmaceuticals inc


Products

The company has one drug on the market, Belviq (lorcaserin), a weight-loss medication. The U.S. Food and Drug Administration (FDA) approved lorcaserin on June 27, 2012. The company commtitted to a sales force commitment of 200. Lorcaserin is approved for use in adults with a body mass index (BMI) of 30 or greater, which is considered obese, or adults with a BMI of 27 or greater and who have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol. However, sales of Belviq were disappointing. In 2015 the company laid off 80 workers; this was followed in July 2016 by the layoff of another 100 employees (approximately 73% of remaining workforce). In January 2017 Arena announced that it is selling Belviq to its Japanese partner, Eisai Co. Ltd., which will manufacture and market the drug; Arena will draw a royalty on global sales.

The sale completes a pivot in emphasis toward drugs still under development. Drugs in the company's pipeline includes medications designed to treat pain, ulcerative colitis and pulmonary arterial hypertension. As of September 2014, potential products that had not yet been approved by the FDA included Temanogrel (thrombotic diseases), Ralinepag (pulmorary arterial hypertension), APD334 (autoimmune disease), APD371 (pain), and Nelotanserin.

References

Arena Pharmaceuticals Wikipedia


Similar Topics
The Witching Hour (1934 film)
George Ayittey
Homero Niño de Rivera
Topics
 
B
i
Link
H2
L